🔗 Share this article

This year's Nobel Prize in Physiology or Medicine has been awarded for revolutionary findings that illuminate how the immune system attacks dangerous pathogens while protecting the healthy tissues.

Three renowned scientists—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this accolade.

The research identified specialized "sentinels" within the defense system that remove malfunctioning immune cells that could attacking the organism.

The findings are now paving the way for innovative treatments for autoimmune diseases and malignancies.

The winners will share a prize fund valued at 11m Swedish kronor.

Decisive Findings

"Their research has been essential for comprehending how the body's defenses functions and why we do not all suffer from serious self-attack conditions," commented the chair of the award panel.

The trio's research address a core mystery: In what way does the immune system protect us from numerous infections while leaving our healthy cells unharmed?

The immune system employs immune cells that scan for indicators of disease, even pathogens and bacteria it has never encountered.

Such cells utilize detectors—called recognition units—that are generated randomly in countless variations.

This gives the immune system the capacity to combat a wide array of threats, but the unpredictability of the mechanism inevitably creates white blood cells that can attack the body.

Security Guards of the Immune System

Scientists earlier knew that some of these harmful white blood cells were destroyed in the immune organ—where white blood cells mature.

The latest award recognizes the discovery of T-reg cells—known as the body's "peacekeepers"—which patrol the body to disarm any immune cells that assault the healthy cells.

We know that this process fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The prize committee stated, "These discoveries have established a new field of research and accelerated the creation of innovative therapies, for instance for cancer and autoimmune diseases."

In cancer, regulatory T-cells block the body from attacking the growth, so studies are focused on reducing their quantity.

For autoimmune diseases, trials are exploring increasing T-reg cells so the body is no longer under attack. A similar approach could also be effective in minimizing the risks of organ transplant failure.

Pioneering Experiments

Professor Shimon Sakaguchi, from Osaka University, conducted experiments on mice that had their thymus extracted, leading to self-attack conditions.

He demonstrated that injecting immune cells from other mice could prevent the illness—suggesting there was a mechanism for preventing immune cells from harming the host.

Mary Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an inherited immune disorder in mice and people that resulted in the discovery of a gene critical for the way T-regs function.

"The pioneering research has uncovered how the body's defenses is kept in check by T-reg cells, preventing it from accidentally targeting the body's own tissues," commented a prominent biological science expert.

"This work is a remarkable illustration of how fundamental biological research can have broad consequences for public health."